Skip to content

Clinical Observation on Treatment of Active Refractory Rheumatoid Arthritis with Huayu Tongbi Decoction

Clinical Observation on Treatment of Active Refractory Rheumatoid Arthritis with Huayu Tongbi Decoction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007418
Enrollment
Unknown
Registered
2015-11-19
Start date
2015-11-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

treatment group:Huayu Tongbi Decoction combined with MTX
controlled group:MTX combined with MTX

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. The patient must meet 1987 American College of Rheumatology classification criteria for the diagnosis of active rheumatoid arthritis and/or 2010 American College of Rheumatology /The European League Against Rheumatism classification criteria for the diagnosis of active rheumatoid arthritis; The patients must meet Class I-III of the Xray development in RA; 2. Patient has signed the informed consent; 3. Patient must be between 18 and 65 years of age.

Exclusion criteria

Exclusion criteria: 1. Infection, pregnancy, lactating, traumatic or other stress state; 2. Severe, progressive or uncontrolled cardiac, hepatic, renal, mental disease; 3. Severe hematologic disease including leukemia, aplastic anemia, myelodysplastic syndrome and so on; 4. Be allergic to the medicine we use in the research; 5. Use antibiotics within 1 month; 6. Patients in the Class? of RA; 7. History of other rheumatic autoimmune disease; 8. Patients with active gastrointestinal disease or pitents with peptic ulcer 4 or less weekly; 9. Patients who have previously participated in any clinical study.

Design outcomes

Primary

MeasureTime frame
DAS28;

Countries

China

Contacts

Public ContactQing-chun Huang
qch1963@163.com+86 13922230939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026